Clinical Trial Update: A Study of HB0025 Injection in Patients With Advanced Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HB0025 injection in patients with advanced renal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cancer

Drugs mentioned

• HB0025

Snippet

Sponsor: Huabo Biopharm Co., Ltd. | Conditions: Renal Cancer | Phase 2 | Status: UNKNOWN